Work

Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma

Year: 2009

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-009-9286-9

Authors: Jennifer Wu, Charles Henderson, Lynn Feun, Peter Van Veldhuizen, Philip Gold, Hui Zheng, Theresa Ryan, Lawrence S. Blaszkowsky, HaoBin Chen, Max Costa, Barry Rosenzweig, MaryLynn Nierodzik, Howard Hochster, Franco Muggia, Giovanni Abbadessa, Jonathan Lewis, Andrew X. Zhu

Institutions: NYU Langone Health, New York University, Piedmont Atlanta Hospital, University of Miami Health System, University of Miami Hospital, Kansas City VA Medical Center, Massachusetts General Hospital, Ziopharm Oncology (United States)

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2055367666

FWCI: 1.344

Cites: 36

Cited by: 39

Related to: 10